B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

DNA Double Strand Break Response

REACTOME PATHWAY
Reactome: R-HSA-569360615 genes295 compounds

The DNA Double Strand Break Response pathway (Reactome ID: R-HSA-5693606) involves 15 genes and is affected by 295 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

ABL1ATMBAP1BARD1BRCA1CHEK2EYA2KDM4AKDM4BMAPK8NSD2PPP5CSUMO1TP53UBE2N

Compounds Affecting DNA Double Strand Break Response

#CompoundTargets HitStudies
1Chlorhexidine299
2Nocodazole Nocodazole is215
3Astemizole Antihistamine drug now withdrawn from280
4Hexachlorophene300
5Axitinib298
6Methotrexate289
7Colchicine300
8cycloheximide300
9Melphalan300
10sp600125117
11Trifluridine295
12vinblastine sulfate81
13Azacitidine298
14Azacitidine300
15Ciclopirox88
16Cytarabine297
17Demecolcine246
18Niclosamide299
19triolimus [Supplementary Concept]33
20Dasatinib299
21Methylene Blue200
22Podophyllotoxin14
23Apigenin 5,7,4'-trihydroxy-flavone,300
24Quercetin300
25Sertraline1,000
26alsterpaullone12
27Fluspirilene74
28kenpaullone8
29lidoflazine278
30Perphenazine297
31Resveratrol298
32rafoxanide172
33Calcimycin216
34Azathioprine300
35Bortezomib300
36Crizotinib298
37Disulfiram297
38Maprotiline299
39alpelisib227
40Clofarabine298
41Decitabine298
42Deferasirox298
43Digitoxin300
44Digoxin299
45Emetine298
46Ethidium300
47monorden8
48Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of300
49pictilisib25
50Sorafenib300

About the DNA Double Strand Break Response Pathway

The DNA Double Strand Break Response pathway is catalogued in Reactome (ID: R-HSA-5693606) and involves 15 genes. In the BiohacksAI corpus, 295 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include ABL1, ATM, BAP1, BARD1, BRCA1.